243 related articles for article (PubMed ID: 29776959)
41. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
[TBL] [Abstract][Full Text] [Related]
42. Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
Frasure-Smith N; Lespérance F; Talajic M; Khairy P; Dorian P; O'Meara E; Roy D
Circ Heart Fail; 2012 May; 5(3):322-30. PubMed ID: 22441774
[TBL] [Abstract][Full Text] [Related]
43. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.
Kay GN; Ellenbogen KA; Giudici M; Redfield MM; Jenkins LS; Mianulli M; Wilkoff B
J Interv Card Electrophysiol; 1998 Jun; 2(2):121-35. PubMed ID: 9870004
[TBL] [Abstract][Full Text] [Related]
44. Safety of cardioversion in atrial fibrillation lasting less than 48 h without post-procedural anticoagulation in patients at low cardioembolic risk.
Tampieri A; Cipriano V; Mucci F; Rusconi AM; Lenzi T; Cenni P
Intern Emerg Med; 2018 Jan; 13(1):87-93. PubMed ID: 28025766
[TBL] [Abstract][Full Text] [Related]
45. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience.
Thibault B; Talajic M; Dubuc M; Guerra P; Gagné P; Roy D; Connolly S;
Can J Cardiol; 2004 Feb; 20(2):195-9. PubMed ID: 15010743
[TBL] [Abstract][Full Text] [Related]
46. A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting.
Du X; Guo L; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Liu X; Yin H; Xuan J; Dong J; Ma C
BMC Cardiovasc Disord; 2017 Jul; 17(1):204. PubMed ID: 28750608
[TBL] [Abstract][Full Text] [Related]
47. Atrial fibrillation in the elderly: facts and management.
Chatap G; Giraud K; Vincent JP
Drugs Aging; 2002; 19(11):819-46. PubMed ID: 12428993
[TBL] [Abstract][Full Text] [Related]
48. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
[TBL] [Abstract][Full Text] [Related]
49. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
[TBL] [Abstract][Full Text] [Related]
50. Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry).
Thind M; Holmes DN; Badri M; Pieper KS; Singh A; Blanco RG; Steinberg BA; Fonarow GC; Gersh BJ; Mahaffey KW; Peterson ED; Reiffel JA; Piccini JP; Kowey PR;
Am J Cardiol; 2018 Nov; 122(10):1677-1683. PubMed ID: 30227964
[TBL] [Abstract][Full Text] [Related]
51. Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry.
Papp J; Zima E; Bover R; Karaliute R; Rossi A; Szymanski C; Troccoli R; Schneider J; Fagerland MW; Camm AJ; Atar D
Eur Heart J Cardiovasc Pharmacother; 2017 Jul; 3(3):147-150. PubMed ID: 28329309
[TBL] [Abstract][Full Text] [Related]
52. Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation.
Tuinenburg AE; Van Gelder IC; Van Den Berg MP; Brügemann J; De Kam PJ; Crijns HJ
Heart; 1999 Oct; 82(4):486-93. PubMed ID: 10490566
[TBL] [Abstract][Full Text] [Related]
53. Prevalence and predictive factors of left atrial tachycardia occurring after second-generation cryoballoon ablation of atrial fibrillation.
Hermida A; Kubala M; Traullé S; Buiciuc O; Quenum S; Hermida JS
J Cardiovasc Electrophysiol; 2018 Jan; 29(1):46-54. PubMed ID: 29024212
[TBL] [Abstract][Full Text] [Related]
54. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).
Lip GY; Laroche C; Ioachim PM; Rasmussen LH; Vitali-Serdoz L; Petrescu L; Darabantiu D; Crijns HJ; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP; Boriani G
Eur Heart J; 2014 Dec; 35(47):3365-76. PubMed ID: 25176940
[TBL] [Abstract][Full Text] [Related]
55. Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey.
Larsen TB; Potpara T; Dagres N; Proclemer A; Sciarrafia E; Blomström-Lundqvist C;
Europace; 2015 May; 17(5):819-24. PubMed ID: 25926476
[TBL] [Abstract][Full Text] [Related]
56. CHA
Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Kaminski M; Musial WJ
Intern Med J; 2017 Mar; 47(3):275-279. PubMed ID: 27860070
[TBL] [Abstract][Full Text] [Related]
57. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
[TBL] [Abstract][Full Text] [Related]
58. CHA
D'Souza M; Carlson N; Fosbøl E; Lamberts M; Smedegaard L; Nielsen D; Torp-Pedersen C; Gislason G; Schou M
Eur J Prev Cardiol; 2018 Apr; 25(6):651-658. PubMed ID: 29482441
[TBL] [Abstract][Full Text] [Related]
59. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.
De Vos CB; Breithardt G; Camm AJ; Dorian P; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Crijns HJ
Am Heart J; 2012 May; 163(5):887-93. PubMed ID: 22607868
[TBL] [Abstract][Full Text] [Related]
60. Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation.
Femia G; Fetahovic T; Shetty P; Lee A
Heart Lung Circ; 2018 Jul; 27(7):798-803. PubMed ID: 28802808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
